Skip to content

FLAMIN-GO

From pathobiology to synovia on chip: driving rheumatoid arthritis to the precision medicine goal

WELCOME

FLAMIN-GO’s Vision

FLAMIN-GO’s VISION is to provide an organ-on-chip solution to open up a new avenue towards personalized care in RA. This solution will be based on the design and fabrication a multi-compartment microfluidic platform, for 3D culturing and perfusion, of all the disease-relevant joint tissues, focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system (vessels and leukocytes) who sustain the disease, as well as cartilage and bone which are the end damaged tissues, leading to permanent disability. The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.

Rheumatoid Arthritis? Chip it!

News

Sensing cells and tissues in disease models: Exploring forces with Cell-Mimicking Beads

November 14th at 6 p.m. (CET) Dr Salvatore Girardo, Max Planck Institute in conversation with Lea Ud…

Science for all, present it so everyone will listen

November 16th at 3 p.m. (CET) Zoom: https://us06web.zoom.us/j/88922457788 Arijana Filipić, PhD, Arij…

Popular Science Writing

November 13th at 3 p.m. (CET) Zoom: https://us06web.zoom.us/j/88922457788 Prof. Saša Novak, PhD, Sci…

Lab on Chip and Point of Care: from idea to production

November 7th at 6 p.m. Laura Boschis, Trustech Srl, Italy in conversation with Lea Udovč, Slovenian …

Contest: AI-ARThritis Visualizing Rheumatoid Arthritis by Artificial Intelligence

Online contest for AI-created images that are related to Rheumatoid Arthritis

Personalized

Organ-on-chip, a multi-compartment microfluidic platform offering tailoring and personalized treatment solutions.

Targeted

Focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system who sustain the disease, as well as cartilage and bone

Monitoring

The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.